Delivery Order SPE2DB24D6039-SPE2DB25FLEJR
Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,728.20 to AmerisourceBergen Drug Corp for the supply of Levofloxacin 25 mg/mL solution in 200 mL quantities. The contract, awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes, with a ceiling value of $2,325.55. This is a firm fixed-price delivery order without set-aside designation, reflecting a competitively awarded procurement. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,842.26 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levocetirizine 2.5 mg/5 ml solution in a 148 ml quantity. The contract utilizes firm fixed price terms and is scheduled for completion by September 29, 2025. This delivery order was awarded through competitive procedures with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement...
- The U.S. Department of Defense's Medical Supply Chain awarded a $4,651.10 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's proven capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes with a contract ceiling value of $7,352.31. This firm fixed-price delivery order, which is not set-aside and carries an ultimate completion date of December 5, 2025, represents a competitively awarded procurement. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.55 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on June 26, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- On September 17, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at approximately $24,956 to AmerisourceBergen Drug Corp for the supply of Loqtorzi 240 mg/6 ml vials. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order is scheduled for completion by October 8, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Moxifloxacin 400 mg/250 ml intravenous bags with a ceiling value of $1,121.02 and an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a single delivery order for the antibiotic medication to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Likmez 500 mg/5 mL suspension in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,298.44 and an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...